Thus, we assumed that nucleolin-targeting gene delivery system could effectively target tumor cells and deliver gene drugs directly into nuclei, which could enhance tumor selectivity and delivery efficacy at the same time. This evidence concerns the gene NUCLEOLIN and neoplasm.